LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Mirxes

Similar companies to Mirxes

Mirxes Tech Stack

Mirxes uses 8 technology products and services including Cloudflare, Font Awesome, RequireJS, and more. Explore Mirxes's tech stack below.

  • Cloudflare
    Content Management System
  • Font Awesome
    Font Scripts
  • RequireJS
    Javascript Frameworks
  • Vue.js
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Webpack
    Miscellaneous
  • YouTube
    Video Players
  • WPForms
    Web Platform Extensions

Media & News

Mirxes's Email Address Formats

Mirxes uses at least 1 format(s):
Mirxes Email FormatsExamplePercentage
FirstLast@mirxes.comJohnDoe@mirxes.com
70%
FirstMiddleLast@mirxes.comJohnMichaelDoe@mirxes.com
12%
FirstLas@mirxes.comJohnDoe@mirxes.com
10%
First.Last@mirxes.comJohn.Doe@mirxes.com
8%

Frequently Asked Questions

Where is Mirxes's headquarters located?

Minus sign iconPlus sign icon
Mirxes's main headquarters is located at 2 Tukang Innovation Grove, JTC MedTech Hub, #09-02 Singapore, 618305 SG. The company has employees across 3 continents, including AsiaNorth AmericaOceania.

What is Mirxes's official website and social media links?

Minus sign iconPlus sign icon
Mirxes's official website is mirxes.com and has social profiles on LinkedIn.

How much revenue does Mirxes generate?

Minus sign iconPlus sign icon
As of October 2024, Mirxes's annual revenue reached $35M.

What is Mirxes's SIC code NAICS code?

Minus sign iconPlus sign icon
Mirxes's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Mirxes have currently?

Minus sign iconPlus sign icon
As of October 2024, Mirxes has approximately 201 employees across 3 continents, including AsiaNorth AmericaOceania. Key team members include Chief Executive Officer: Y. W.Chief Investor Relations Officer: M. L.Chief Investment Officer: I. H.. Explore Mirxes's employee directory with LeadIQ.

What industry does Mirxes belong to?

Minus sign iconPlus sign icon
Mirxes operates in the Biotechnology Research industry.

What technology does Mirxes use?

Minus sign iconPlus sign icon
Mirxes's tech stack includes CloudflareFont AwesomeRequireJSVue.jsjQuery MigrateWebpackYouTubeWPForms.

What is Mirxes's email format?

Minus sign iconPlus sign icon
Mirxes's email format typically follows the pattern of . Find more Mirxes email formats with LeadIQ.

How much funding has Mirxes raised to date?

Minus sign iconPlus sign icon
As of October 2024, Mirxes has raised $50M in funding. The last funding round occurred on Jul 25, 2023 for $50M.

When was Mirxes founded?

Minus sign iconPlus sign icon
Mirxes was founded in 2014.
Mirxes

Mirxes

Biotechnology ResearchSingapore, Singapore201-500 Employees

Mirxes is a Singapore-headquartered biotechnology company whose mission is to save lives through early, actionable, and personalized diagnoses across the care continuum.

We are Asia-centered, starting with Southeast Asia, and have global ambitions. We have research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. We have sales and distribution networks worldwide.

Our flagship product is GASTROClear, the world’s first molecular blood test for early detection of gastric cancer, able to detect around 90% of patients with Stage I and II cancers. 

We continue to build a comprehensive cancer portfolio with early detection tests for lung and thyroid cancer (2022), colorectal and breast cancer (2023), liver and ovarian cancer (2024). We are concurrently building a precision oncology portfolio to provide clinical insights for the complete patient journey.

MiRXES was spun off from A*STAR’s Bioprocessing Technology Institute in 2014 to commercialize an industry-leading qPCR-based technology for microRNA detection. Our ID3EAL discovery tool and workflow has been adopted by top academic and industry partners globally and is backed by the world’s first industry standard for microRNA-base diagnostics.

Our versatile platform technology and capabilities have broad applications in the discovery of biomarkers and diagnosis of diseases. We are starting with early cancer detection, but we will also be addressing unmet clinical needs in cardiovascular, metabolic, and infectious diseases.

We responded to COVID-19 by leveraging our capabilities to mass produce and distribute over 5 million units of the Fortitude COVID-19 RT-PCR test. This made-in-Singapore diagnostic test, developed by A*STAR and Tan Tock Seng Hospital, has been deployed in 13 Singapore hospitals and clinical labs and exported to over 45 countries worldwide. Post-COVID, we will leverage this network to commercialize multi-cancer early detection tests.

Section iconCompany Overview

Headquarters
2 Tukang Innovation Grove, JTC MedTech Hub, #09-02 Singapore, 618305 SG
Website
mirxes.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $50M

    Mirxes has raised a total of $50M of funding over 4 rounds. Their latest funding round was raised on Jul 25, 2023 in the amount of $50M.

  • $10M$50M

    Mirxes's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $50M

    Mirxes has raised a total of $50M of funding over 4 rounds. Their latest funding round was raised on Jul 25, 2023 in the amount of $50M.

  • $10M$50M

    Mirxes's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.